Biblio Discovery — Demo Discovery Service

6 results for "Luczak, Adam"

Showing 1–6 · 0.71 seconds · RSS

  1. Journal Article Full text

    Fully inkjet-printed flexible organic voltage inverters as a basic component in digital NOT gates

    Luczak, Adam; Mitra, Kalyan Y.; Baumann, Reinhard R. et al.

    Sci Rep · 2022 · English · PubMed Central

    In relation to conventional vacuum-based processing techniques inkjet printing enables upscaling fabrication of basic electronic elements, such as transistors and diodes. We present the fully inkjet printed flexible electronic circuits, including organic voltage inverter which can work as a NOT…

  2. Journal Article Full text

    The Quinonoid Zwitterion Interlayer for the Improvement of Charge Carrier Mobility in Organic Field-Effect Transistors

    Luczak, Adam; Ruiz, Angélina Torres; Pascal, Simon et al.

    Polymers (Basel) · 2021 · English · PubMed Central

    The interface between the semiconductor and the dielectric layer plays a crucial role in organic field-effect transistors (OFETs) because it is at the interface that charge carriers are accumulated and transported. In this study, four zwitterionic benzoquinonemonoimine dyes featuring alkyl and aryl…

  3. Journal Article Full text

    Increased Soluble PD-1 Predicts Response to Nivolumab plus Ipilimumab in Melanoma

    Pedersen, Jesper Geert; Sokac, Mateo; Sørensen, Boe Sandahl et al.

    Cancers (Basel) · 2022 · English · PubMed Central

    SIMPLE SUMMARY: Checkpoint inhibitors have emerged as an effective therapy for patients with metastatic melanoma significantly improving survival for these patients. Despite this, many patients do not respond to the therapy and no current biomarkers can identify responders from non-responders…

  4. Journal Article Full text

    Analysis of circulating tumor DNA during checkpoint inhibition in metastatic melanoma using a tumor-agnostic panel

    Kisistók, Judit; Christensen, Ditte Sigaard; Rasmussen, Mads Heilskov et al.

    Melanoma Res · 2023 · English · PubMed Central

    Immunotherapy has revolutionized treatment of patients diagnosed with metastatic melanoma, where nearly half of patients receive clinical benefit. However, immunotherapy is also associated with immune-related adverse events, which may be severe and persistent. It is therefore important to identify…

  5. Journal Article Full text

    Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A Real-World Data Study

    Fink, Morten; Vittrup, Anders Schwartz; Bastholt, Lars et al.

    Cancers (Basel) · 2021 · English · PubMed Central

    SIMPLE SUMMARY: This retrospective study of real-world patients with metastatic melanoma shows that discontinuing treatment with combination immunotherapy due to adverse events does not result in a poorer outcome compared to patients that did not discontinue due to toxicity. This is important…

  6. Journal Article Full text

    Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study

    Buhl, Anna Sofie Kappel; Christensen, Troels Dreier; Christensen, Ib Jarle et al.

    Breast Cancer Res Treat · 2018 · English · PubMed Central

    PURPOSE: Anthracyclines remain a cornerstone in the treatment of primary and advanced breast cancer (BC). This study has evaluated the predictive value of a multigene mRNA-based drug response predictor (DRP) in the treatment of advanced BC with epirubicin. The DRP is a mathematical method combining…